Hasil Pencarian  ::  Simpan CSV :: Kembali

"The prevalence of coronary heart disease in the adult population with diabetes mellitus (DM) is far greater (55%) than in the general public (2-4%). There is an acknowledged correlation between type I hidden ischemia and the incidence of myocardiac infarct. There needs to be a way to determine the presence or absence of ischemia. An alternative examination method is the Dobutamine Stress Echocardiography (DSE).This study was conducted at the Metabolic-Endocrine and the Cardiology Out-Patient Clinics of the Department of Internal Medicine ofCipto Mangunkusumo Central Public General Hospital, Jakarta, from February to August 2001.The aim of the study is to detect undetected myocardiac ischemia using the electrocardiography among patients with type 2 diabetes mellitus and podiatric abnormality and testing the correlation between certain factors (sex, age, body mass index, lipid profile, fasting blood glucose, post prandial blood glucose, HbAlc, peripheral vascular disease, smoking, retinopathy, and neuropathy) with myocardiac ischemia.Methodology: The study was designed as a comparative study of the incidence of myocardiac ischemia between type 2 diabetes mellitus patients with and without podiatric abnormalities. The sample consisted of 28 patients. Samples underwent the dobutamine stress echocardiographyResults: dobutamine stress echocardiography examination using Apogee on 14 patients with type 2 diabetes mellitus with podiatric abnormality demonstrated a positive ischemic response in 4 people (28.6%). No positive findings were found in type 2 diabetes mellitus patients without podiatric abnormality.Conclusion: 1. DSE could detect myocardiac ischemia in 28.6% of type 2 diabetes mellitus undetected with electrocardiography. 2. Other factors that influenced a positive dobutamine stress echocardiography were autonomic neuropathy, diabetic retinopathy, the duration of diabetes mellitus, fasting blood glucose, and podiatric abnormality."

"The aim of this study was to investigate the increase in neutrophil count and the decrease in both phagocytosis and neutrophil oxidative burst (formation of radical oxygen) among type 2 diabetes mellitus (DM) patients and the normal range of phagocytosis function and oxidative burst in neutrophil from Non-DM control subjects. The aim of this study is also to investigate the factors that influence neutrophil count, phagocytosis function and neutrophil oxidative burst among type 2 diabetes mellitus (DM) patients. The examination was conducted using a flow cytometry. The study subjects were 142 type 2 DM patients and 65 Non-DM control subjects. Statistical analysis was performed using the Mann Whitney test and linear regression analysis. The results of this study indicated that there is impaired neutrophil function among type 2 DM patients. The results of this study also showed a correlation between Hemoglobin level, age, platelet count, and SGPT vs. neutrophil phagocytosis function, as well as a correlation between HDL cholesterol and (fMLP-stimulated) neutrophil oxidative burst. The study also showed a correlation between sex and stroke and (S. sureus-stimulated) neutrophil radical oxygen formation, a correlation between neutrophil count and platelet count, a correlation offibAlc and fasting blood glucose level and (fMLP-stimulated) neutrophil radical oxygen formation. In a multivariate analysis, when adjusted to age and sex, there was a correlation between triglyceride and (baseline) neutrophil radical oxygen formation and between HDL cholesterol and (fMLP-stimulated) neutrophil radical oxygen formation."

"Latar Belakang: Buruknya manajemen diabetes melitus tipe 2 menyebabkan peningkatan komplikasi dan tingginya morbiditas sehingga diperlukan adanya pendampingan pasien berkelanjutan dalam menjalankan manajemen dirinya. Stres dapat berkaitan timbal balik dengan penurunan manajemen diri. Salah satu intervensi nonfarmakologis untuk menurunkan tingkat stres dan meningkatkan manajemen diri adalah edukasi pasien dengan metode blended menggunakan web apps "diabetacare". Edukasi ini terdiri dari beberapa pendekatan pembelajaran seperti video tutorial, pemantauan diri dan konsultasi, sehingga pasien dapat belajar dan menerapkan pendidikan berkelanjutan dalam kehidupan sehari-hari. Penelitian ini bertujuan untuk menguji pengaruh edukasi blended menggunakan web apps “diabetacare” terhadap tingkat stres dan manajemen diri pasien DM tipe 2. Bahan dan Metode: Penelitian ini menggunakan pendekatan quasi eksperimental pretestposttest control group design terhadap 54 responden yang dibagi rata menjadi 2 kelompok. Program edukasi blended menggunakan web apps “Diabetacare” diberikan selama 3 minggu. Instrumen penelitian ini menggunakan DASS 21 (Depression Anxiety Stress Scale) untuk mengukur tingkat stres dan kuesioner M Tingkat stres dan manajemen diri responden telah diukur pada saat sebelum dan sesudah intervensi, kemudian dianalisis dengan uji wilcoxon dan mann-whitney. manajemen diri. Hasil: Terdapat perbedaan yang signifikan antara rata-rata skor tingkat stres dan manajemen diri antara kelompok intervensi dan kelompok kontrol sesudah diberikan intervensi (p = 0,000 dan p=0,000 ). Kesimpulan: Hasil penelitian ini menunjukkan bahwa edukasi blended menggunakan web apps “Diabetacare” berpengaruh terhadap penurunan tingkat stres dan peningkatan manajemen diri pada pasien DM tipe 2.

---

Background: Poor management of type 2 diabetes mellitus causes increased complications and high morbidity, so that ongoing patient assistance is needed in carrying out self-care. Stress can be reciprocally related to decreased self-care. One non-pharmacological intervention to reduce stress levels and increase selfcare is patient education using a blended method using the "diabetacare" web app. This education consists of several learning approaches such as video tutorials, selfmonitoring and consultation, so that patients can learn and apply continuing education in their daily lives. This study aims to test the effect of blended education using the "diabetacare" web app on the stress level and self-care of type 2 DM patients. Materials and Methods: This study used a quasi-experimental Pretest- Posttest Control Group Design approach with 54 respondents who were divided equally into 2 groups . The blended educational program using the "Diabetacare" web app is provided for 3 weeks. This research instrument uses the DASS 21 (Depression Anxiety Stress Scale) to measure stress levels and a self-care questionnaire. The respondents' levels of stress and self-care were measured before and after the intervention, then analyzed using the Wilcoxon and Mann-Whitney tests. Component scores were compared between the two groups. Results: There was a significant difference between the average stress and self-care level scores between the intervention group and the control group after being given the intervention (p = 0.000 and p = 0.000). Conclusion: The results of this study show that blended education using the "diabetacare" web app has an effect on reducing stress levels and increasing self-care in type 2 DM patients."

"Kepatuhan perawatan diri diabetes berdampak positif terhadap peningkatan outcome klinis. Hasil penelitian terdahulu pada penyandang diabetes melitus tipe 2 menunjukkan kepatuhan perawatan diri yang buruk. Inovasi teknologi dapat menjadi alternatif solusi dalam mengatasi masalah ini. Penelitian bertujuan mengetahui pengaruh aplikasi berbasis web terhadap perilaku kepatuhan perawatan diri pada pasien diabetes melitus tipe 2. Penelitian ini berdesain quasi eksperimental pre-posttest dengan kelompok kontrol. Partisipan direkrut di program prolanis di klinik dan persadia. Analisis data menggunakan komputerisasi pada 56 responden. Pada analisis bivariat, terdapat peningkatan skor kepatuhan pada kelompok intervensi di akhir penelitian yang tidak bermakna (p=0,649) dan terjadi penurunan skor kepatuhan yang tidak bermakna pada kelompok kontrol (p=0,490). Tidak ada pengaruh penggunaan aplikasi terhadap perilaku diabetes (p=0,433). Pada analisis multivariat, didapatkan hubungan yang signifikan antara tingkat pendidikan (p=0,007) terhadap skor kepatuhan posttest. Aplikasi peduli diabetes berpotensi meningkatkan skor kepatuhan perawatan diri. Perbaikan desain aplikasi diharapkan dapat meningkatkan efektivitas penggunaan aplikasi.

---

Diabetes self-care adherence has a positive impact on improving clinical outcomes. Observations in people with type 2 diabetes mellitus show poor self-care adherence. Technological innovation can be an alternative solution to overcome this problem. The research aims to determine the effect of web-based applications on self-care adherence behavior in type 2 diabetes mellitus patients. This research has a quasi-experimental pre-posttest design with a control group. Participants were recruited in the prolanis program at the clinic and persadia. Data analysis used computerization on 56 respondents. In bivariate analysis, there was an increase in adherence scores in the intervention group at the end of the study which was not significant (p=0.649) and a decrease in adherence scores which was not significant in the control group (p=0.490). There was no effect of application use on diabetes behavior (p=0.433). In multivariate analysis, a significant relationship was found between education level (p=0.007) and posttest adherence scores. The Peduli Diabetes application has the potential to improve self-care adherence scores. Improvements in application design are expected to increase the effectiveness of application use."

"Beberapa studi epidemiologi maupun studi metaanalisis menunjukkan beberapa faktor pada DM tipe 2 memiliki hubungan dengan risiko terjadinya kanker. Mutan p53 yang terbukti berkontribusi terhadap perkembangan tumor sementara insulin yang diketahui berperan dalam mengendalikan kadar gula tubuh, dipilih menjadi biomarker yang akan diteliti pada penelitian ini. Penelitian ini bertujuan untuk mempelajari hubungan kadar mutan p53 dan insulin pada kelompok pasien DM tipe 2 + kanker (n=51) dan pasien DM tipe 2 (n=51). Penelitian ini merupakan penelitian cross-sectional dengan teknik pengambilan sampel consecutive sampling. Pada penelitian, diketahui tidak terdapat perbedaan yang bermakna (p=0,774) pada nilai mutan p53 antara kelompok pasien DM tipe 2 + kanker (1,65±0,10 ng/mL) dan kelompok pasien DM tipe 2 (1,62±0,09 ng/mL). Terdapat perbedaan bermakna (p<0,001) pada kadar insulin antara kelompok pasien DM tipe 2 + kanker (19,33±2,68 µIU/mL) dan kelompok pasien DM tipe 2 (37,31±2,68 µIU/mL). Tidak terdapat korelasi bermakna antara kadar mutan p53 dengan kadar insulin pada kelompok pasien DM tipe 2 + kanker (r=0,191; p= 0,179) dan pada kelompok pasien DM tipe 2 (r=-0,081; p= 0,574). Berdasarkan hasil penelitian, dapat disimpulkan bahwa tidak ada perbedaan bermakna pada kadar mutan p53 antara kelompok pasien DM tipe 2 + kanker dan kelompok pasien DM tipe 2, namun terdapat perbedaan pada kadar insulin pada kedua kelompok. Selain itu, tidak ada korelasi bermakna antara kadar mutan p53 dan insulin pada kedua kelompok.

---

Epidemiological studies and meta-analysis have shown that several factors in type 2 DM are related to cancer incidents. Mutant p53 is scientifically proven to contribute in tumor development while insulin that known well to play an important role in controlling body glucose levels, therefore those two biomarkers were chosen to be investigated in this study. This research aimed to study the correlation of mutant p53 and insulin in type 2 DM + cancer (n=51) and type 2 DM patients (n=51). This research was a cross-sectional study with consecutive technique sampling. This study showed that there was no significant difference (p=0.774) of mutant p53 value between type 2 DM + cancer patients group (1.65±0.10 ng/mL) and type 2 DM patients group (1.62±0.09 ng/mL). However, it was significant difference (p<0.001) of insulin value in type 2 DM + cancer patients group (19.33±2.68 µIU/mL) and type 2 DM patients group (37.31±2.68 µIU/mL). There was also no significant correlation between mutan p53 and insulin value in type 2 DM + cancer patients group (r=0.191; p=0.179) and type 2 DM patients group (r=-0.081; p=0.574). Based on the results, we concluded that there was no significant difference of mutant p53 value in type 2 DM + cancer patients group and in type 2 DM patients group but there was significant difference of insulin value in both groups. There was also no significant correlation between mutan p53 and insulin value in both groups."

"Penderita Diabetes Melitus (DM) Tipe 2 mengalami peningkatan risiko kanker yang diduga diakibatkan oleh kondisi hiperglikemia, hiperinsulinemia, dan inflamasi. Ketiga faktor tersebut dapat menginduksi proses tumorigenesis melalui jalur glukotoksisitas, lipotoksisitas, dan stres oksidatif. Penelitian ini bertujuan untuk mengukur dan membandingkan mutan p53 sebagai tumor marker pada pasien DM tipe 2 dan pasien DM tipe 2 yang menderita kanker, mengukur dan membandingkan HbA1c pada kedua kelompok, serta melihat korelasi mutan p53 dengan HbA1c pada kedua kelompok. Desain studi yang digunakan adalah cross-sectional dengan teknik pengambilan sampel consecutive sampling. Kelompok yang diteliti pada penelitian ini adalah pasien DM tipe 2 (n = 51) dan pasien DM tipe 2 yang menderita kanker (n = 51). Analisis mutan p53 pada serum sampel dilakukan menggunakan ELISA, sedangkan pengukuran HbA1c dilakukan dengan Afinion Analyzer. Pada penelitian ini kadar serum mutan p53 pada kelompok pasien DM tipe 2 (1,62 ± 0,08 ng/ml) tidak berbeda bermakna dengan kelompok pasien DM tipe 2 yang menderita kanker (1,64 ± 0,09 ng/ml) (p = 0,774). Sementara itu, HbA1c pada kelompok DM tipe 2 (8,42 ± 0,25 %) berbeda bermakna dengan kelompok DM tipe 2 yang menderita kanker (7,02 ± 0,20 %) (p < 0,001). Tidak terdapat hubungan yang bermakna antara kadar mutan p53 dengan HbA1c, baik pada kelompok DM tipe 2 (r = 0,083; p = 0,561), maupun kelompok DM tipe 2 yang menderita kanker (r = 0,072; p = 0,617). Penelitian ini menunjukkan bahwa kadar mutan p53 pada kelompok DM tipe 2 dan DM tipe 2 yang menderita kanker tidak berbeda bermakna, namun HbA1c pada kedua kelompok berbeda bermakna. Sementara itu, tidak terdapat hubungan yang bermakna antara kadar mutan p53 dengan HbA1c pada kedua kelompok.

---

Type 2 Diabetes Mellitus has been found to increase the risk of cancer which is caused by conditions of hyperglycemia, hyperinsulinemia, and inflammation. These three factors are able to induce tumorigenesis through mechanisms of glucotoxicity, lipotoxicity, and oxidative stress. This study aimed to measure and compare mutant p53 as tumor marker in Type 2 Diabetes Mellitus patients and Type 2 Diabetes Mellitus patients with cancer, to measure and compare HbA1c level in both groups, and to analyze the correlation between mutant p53 and HbA1c level in both groups. This study was a cross-sectional study with consecutive sampling technique in which two groups were involved, namely type 2 diabetes mellitus patients (n = 51) and type 2 diabetes mellitus patients with cancer (n = 51). Serological level of mutant p53 protein was analyzed using ELISA and HbA1c was measured with HbA1c Afinion Analyzer.

The serological level of mutant p53 in the type 2 diabetes mellitus patients (1.62 ± 0.08 ng/ml) showed no significant difference compared with type 2 diabetes mellitus patients with cancer (1.64 ± 0.09 ng/ml) (p = 0.774). Meanwhile, HbA1c level showed significant difference between type 2 diabetes mellitus patients (8.42 ± 0.25 %) and type 2 diabetes mellitus patients with cancer (7.02 ± 0.20 %) (p < 0.001). Mild correlations between mutant p53 and HbA1c level were found in both type 2 diabetes mellitus patients (r = 0.083; p = 0.561) and type 2 diabetes mellitus patients with cancer (r = 0.072; p = 0.617). Based on the result, there was no significant difference between mutant p53 in type 2 diabetes mellitus patients with and without cancer. HbA1c level was found to be significantly different in both groups. Meanwhile, there was no significant correlation between mutant p53 and HbA1c in both groups."

"Latar Belakang: Sindroma dispepsia sering dialami oleh penderita DM. Asam lambung salah satu faktor agresif terjadinya sindroma dispepsia dan tukak lambung. Penelitian ini bertujuan untuk mencari perbedaan pH lambung pada pasien dispepsia DM dengan yang bukan DM dan untuk mengetahui apakah ada korelasi antara pH lambung dengan proteinuria dan HbA1c. Metode: Pasien terdiri dari 30 kelompok DM dan 30 kelompok bukan DM. Masing-masing kelompok dihitung pH lambung basal. pH lambung basal diukur dgn memasukkan elektroda kateter kedalam lambung selama 30 menit kemudian di rekam dgn alat PH Metri merek Digitrapper pH-Z. Beratnya komplikasi DM diukur dengan mikroalbuminuria, sedangkan kendali gula darah diukur dgn HbA1c. Dilakukan uji chi square utk mencari perbedaan pH lambung kelompok DM dgn yg bukan DM, dengan terlebih dahulu menentukan titik potong dgn analisa ROC (Receiver Operating Caracteristic). Dilakukan uji korelasi antara pH lambung basal dengan mikroalbuminuria dan HbA1c pada kelompok pasien DM. Hasil: pH lambung basal pada dispepsia DM vs non DM (2.30±0.83 vs 2.19±0.52). Dgn uji chi square terdapat perbedaan bermakna antara kelompok DM dengan yang bukan DM. Pada uji korelasi antara pH lambung dengan mikroalbuminuria dijumpai r = 0.47 dan p < 0.05, sedangkan HbA1c dijumpai r=0,59 dan p > 0.05. Simpulan: Ada perbedaan bermakna pH lambung basal antara pasien dispepsia DM dengan pasien dispepsia bukan DM. Ada korelasi antara pH lambung basal dengan mikroalbuminuria, sedangkan dengan HbA1c tidak ada korelasi. pH lambung basal pada pasien DM adalah 2.03±0.83 sedangkan pada yang bukan DM adalah 2.19±0.52.

---

Aims: Dyspepsia syndrome often experienced in diabetic patients. Gastric acid was one aggressive factors in dyspepsia syndrome. This aim of this study was to determine differences gastric pH between dyspepsia diabetic and dispepsia without diabetic patients. Also to determine whether there were a correlation between basal gastric pH and microalbuminuria and also HbA1c.

Methods: There were 30 patients diabetic and 30 patients without diabetic. Basal gastric pH was measured with an electrode catheter that inserted into the stomach for 30 minutes. Gastric pH will be recorded with PH Metri Digitrapper pH-Z. Diabetic complications measured by microalbuminuria, while the measured blood sugar control with HbA1c. Chi-square test to determine differences gastric pH between diabetic and without diabetic patients. Correlation test was performed between basal gastric pH and microalbuminuria and also HbA1c.

Results: We found basal gastric pH diabetic and non diabetic patients were (2.30±0.83 vs 2.19±0.52). There was significant differences between diabetic and non diabetic patients. From 30 diabeic patients we found a corelation between basal gastric pH and microalbuminuria (p < 0.05 and r = 0.47) and a no corelation with HbA1c (p > 0.05 and r=0,59).

Conclusions: There was significant differences basal gastric pH between diabetic and non diabetic patients. There was correlation between basal gastric pH and microalbuminuria, and no correlation with HbA1c. Basal gastric pH diabetic patients was 2,30 ± 0.83 and non diabetic patients was 2,19 ± 0,52."